Dipna Pharmachem (BOM:543594) FCF Margin % : 1.57% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Dipna Pharmachem FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dipna Pharmachem's Free Cash Flow for the six months ended in Mar. 2024 was ₹14 Mil. Dipna Pharmachem's Revenue for the six months ended in Mar. 2024 was ₹903 Mil. Therefore, Dipna Pharmachem's FCF Margin % for the quarter that ended in Mar. 2024 was 1.57%.

As of today, Dipna Pharmachem's current FCF Yield % is -27.71%.

The historical rank and industry rank for Dipna Pharmachem's FCF Margin % or its related term are showing as below:

BOM:543594' s FCF Margin % Range Over the Past 10 Years
Min: -21 Med: -7.86 Max: 3.85
Current: -3.3

During the past 5 years, the highest FCF Margin % of Dipna Pharmachem was 3.85%. The lowest was -21.00%. And the median was -7.86%.

BOM:543594's FCF Margin % is ranked worse than
62.59% of 671 companies
in the Healthcare Providers & Services industry
Industry Median: 1.46 vs BOM:543594: -3.30

Dipna Pharmachem FCF Margin % Historical Data

The historical data trend for Dipna Pharmachem's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dipna Pharmachem FCF Margin % Chart

Dipna Pharmachem Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

-10.21

-7.86

3.85

-21.00

-3.30

Dipna Pharmachem Semi-Annual Data
	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
FCF Margin %	Get a 7-Day Free Trial			-	0.70	-41.55	-9.25	1.57

Competitive Comparison of Dipna Pharmachem's FCF Margin %

For the Pharmaceutical Retailers subindustry, Dipna Pharmachem's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dipna Pharmachem's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dipna Pharmachem's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Dipna Pharmachem's FCF Margin % falls into.

Dipna Pharmachem FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Dipna Pharmachem's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	-54.311	/	1643.371
	=	-3.30 %

Dipna Pharmachem's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	14.16	/	903.053
	=	1.57 %

Dipna Pharmachem FCF Margin % Related Terms

Thank you for viewing the detailed overview of Dipna Pharmachem's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dipna Pharmachem (BOM:543594) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dipna Pharmachem Ltd (BOM:543594) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380 055

Website

https://www.dipnapharmachem.com

Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone and others.

Dipna Pharmachem (BOM:543594) Headlines

No Headlines